English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduExperts in infection prevention and control available for interview about research findings and other breaking health topics including the flu, COVID, HIV, mpox, West Nile, and vaccinations
Tag: mpox
FAU Researchers Confront New U.S. and Global Challenges in Vaccinations of Adults
Over the past decade, decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. and globally. Researchers discuss the multifactorial barriers including increasing vaccine hesitancy and new clinical and public health challenges in vaccinations of U.S. adults.
Mpox Vaccine Antibody Responses Waned within a Year, Study Shows
Research shows people previously vaccinated against mpox in 2022 had declining antibody responses after six to 12 months, as World Health Organization (WHO) designates the 2024 mpox outbreak a public health emergency of international concern.
Media Briefing: Flu Season, COVID, Mpox, Avian Flu, and Parvovirus – Tackling the Spread & Seeking Protection
The Johns Hopkins Bloomberg School of Public Health will host an expert briefing for the media about the spread of various infectious diseases, including seasonal influenza, COVID-19, mpox, avian flu, and parvovirus. Experts will discuss the risks, increases in cases,…
Expert Briefing: Flu Season, COVID, Mpox, Avian Flu, and Parvovirus
The Johns Hopkins Bloomberg School of Public Health will host an expert briefing for the media about the spread of various infectious diseases, including seasonal influenza, COVID-19, mpox, avian flu, and parvovirus. Experts will discuss the risks, increases in cases,…
The latest mpox outbreak and its threat to vision
Monkeypox virus (mpoxv) has re-emerged, designated on August 14 as a global emergency by the World Health Organization. Newly evolved strains of mpox viruses can efficiently spread among people. In addition to skin rashes, mpox infection can cause eye complications including inflammation of the clear tissue covering the iris and pupil called the cornea (keratitis), the tissue covering the white of the eye and the underside of the eyelid (conjunctivitis, or pink eye), and the eyelid (blepharitis).
Global Health Expert to Discuss Africa’s Mpox Response and Vaccine Equity
Professor Helen Rees Chairs the WHO African Regional Technical Advisory Group on Immunization and co-chairs National Department Mpox Incident Management Team overseeing South Africa’s Mpox response. She is a member of the African CDC Emergency Consultative Group that declared MPOX…
Rutgers School of Public Health Dean Available to Speak on Mpox Public Health Emergency
Perry N. Halkitis, Dean of the Rutgers School of Public Health, is available to speak on the WHO declaring mpox a public health emergency of international concern.
Mpox continues to circulate at low numbers among gay and bisexual men who have sex with men
Mpox continues to circulate in the U.S. among gay and bisexual men who have sex with men. Though the number fell sharply to only 3 cases during the June through December 2023 multisite surveillance period compared to the previous highs, concern for its reemergence continues due to, among other things, incomplete knowledge among other groups.
Wake Forest University School of Medicine, Advocate Health and Vysnova Partners Awarded $3.4 Million Contract by CDC to Lead Large-Scale Sexually Transmitted Infection Research Project
Wake Forest University School of Medicine, Advocate Health and Vysnova Partners have been awarded a $3.4 million, four-year contract to study HIV, Mpox and other sexually transmitted infections (STIs).
Faster Monkeypox (mpox) Testing Through CRISPR
Mpox, formerly known as monkeypox, is a rare viral disease that is spread through physical contact between people.
Reductions in sexual mixing ended mpox outbreak in England, while vaccination has prevented resurgences in 2023
The rapid outbreak of mpox (formerly known as monkeypox) in 2022 likely resulted from high levels of sexual mixing among some gay, bisexual and other men who have sex with men (GBMSM), with the initial downturn in cases probably due to a reduction in sexual contacts among these men.
Researchers describe case of tecovirimat-resistant mpox variant in patient with prolonged infection
Authors from the Institute of Tropical Medicine, Nationalestraat, Antwerp, Belgium describe a case of tecovirimat-resistant mpox virus (MPXV) identified at the autopsy of a severely immunocompromised patient with prolonged disease. Tecovirimat, an antiviral used to treat severe mpox virus, has a low barrier to resistance, which makes this case particularly unusual. The case report is published in Annals of Internal Medicine.
A UCLA-led team has received a $925,000 CDC grant to track mpox outbreaks across the US
A UCLA-led team has received $925,000 as part of a new grant from the Centers for Disease Control and Prevention (CDC) to conduct four surveillance projects tracking outbreaks of mpox–formerly known as monkeypox—across the U.S.
Mpox Antiviral Outcomes Are Similar Regardless of HIV Status
Patients with mpox who were treated with the antiviral drug tecovirimat had similar outcomes regardless of HIV status, find researchers at Columbia University and Weill Cornell Medicine.
Mpox modeling suggests timely detection, isolation could prevent significant spread on college campuses
A model of mpox transmission among students living on a college campus suggests that sustained transmission could be significantly reduced with timely detection and isolation on its own. The model also showed that preventative vaccination of the high-risk population could help limit the size and scope of outbreaks. The findings are published in Annals of Internal Medicine.
What You Should Know About Mpox
Find out what special pathogens expert Erika Cheung, MSN, RN, CPN, has to say about the disease, which the WHO has declared a public health emergency of international concern. Since May 18, 2022, cases of mpox have been spreading in the United States, including California. On July 23, 2022, the World Health Organization (WHO) declared the current outbreak a public health emergency of international concern.
Early engagement with affected communities helped to control mpox outbreak in Montreal
An analysis of the first large mpox outbreak in North America found that early, sustained engagement and rapid offering of preexposure vaccination to affected communities successfully controlled the spread of the outbreak. The analysis is published in Annals of Internal Medicine.